Foresite Capital Fund VI LP - Significant Ownership

Signature - Title
/s/ James B. Tananbaum - James Tananbaum, Managing Member of the General Partner
Location
Larkspur, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Foresite Capital Fund VI LP.

Significant Ownership of Foresite Capital Fund VI LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALMS Alumis Inc. Common Stock 15.9% $67.8M 15.2M 0% James B. Tananbaum May 21, 2025
RAPT RAPT Therapeutics, Inc. Common Stock 9.3% $10.6M 12.5M Foresite Capital Fund VI, L.P. Dec 23, 2024
CASI CASI Pharmaceuticals, Inc. Ordinary Shares, par value $0.0001 5.1% $929K 787K Foresite Capital Fund VI, L.P. Jun 30, 2025
ENGN enGene Holdings, Inc. Common Shares, no par value 0% $0 0 Foresite Capital Fund VI, L.P. Sep 30, 2024

Schedules 13D/G Reported by Foresite Capital Fund VI LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.